The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models—association with liver and adipose tissue effects
Abstract
Recombinant fibroblast growth factor (FGF)21 has antihyperglycemic, antihyperlipidemic, and antiobesity effects in diabetic rodent and monkey models. Previous studies were confined to measuring steady-state effects of FGF21 following subchronic or chronic administration. The present study focuses on the kinetics of biological actions of FGF21 following a single injection and on the associated physiological and cellular mechanisms underlying FGF21 actions. We show that FGF21 resulted in rapid decline of blood glucose levels and immediate improvement of glucose tolerance and insulin sensitivity in two animal models of insulin resistance ( ob/ob and DIO mice). In ob/ob mice, FGF21 led to a 40–60% decrease in blood glucose, insulin, and amylin levels within 1 h after injection, and the maximal effects were sustained for more than 6 h despite the 1- to 2-h half-life of FGF21. In DIO mice, FGF21 reduced fasting blood glucose and insulin levels and improved glucose tolerance and insulin sensitivity within 3 h of treatment. The acute improvement of glucose metabolism was associated with a 30% reduction of hepatic glucose production and an increase in peripheral glucose turnover. FGF21 appeared to have no direct effect on ex vivo pancreatic islet insulin or glucagon secretion. However, it rapidly induced typical FGF signaling in liver and adipose tissues and in several hepatoma-derived cell lines and differentiated adipocytes. FGF21 was able to inhibit glucose release from H4IIE hepatoma cells and stimulate glucose uptake in 3T3-L1 adipocytes. We conclude that the acute glucose-lowering and insulin-sensitizing effects of FGF21 are potentially associated with its metabolic actions in liver and adipose tissues.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Once secreted, FGF21 has a short half-life of approximately 0.5–1.5 hours (refs. 40,41).”
From Metabolic messengers: FGF21 (2021) · cites this paper as [41]
In the citing paper
“This decrease in plasma glucose levels occurs primarily through increased peripheral glucose disposal41,56,65, although decreases in hepatic glucose production have also been observed66.”
From Metabolic messengers: FGF21 (2021) · cites this paper as [41]
In the citing paper
“A single injection of FGF21 can decrease plasma glucose levels by more than 50% in animal models with genetically induced and diet-induced obesity41,65.”
From Metabolic messengers: FGF21 (2021) · cites this paper as [41]
In the citing paper
“KLB expression is primarily restricted to specific metabolic tissues (for example, the liver, pancreas and adipose tissue)5, and lower expression is observed in the brain22,48–50. Despite some reports to the contrary51,52, KLB is not expressed in muscle5,41.”
From Metabolic messengers: FGF21 (2021) · cites this paper as [41]
In the citing paper
“FGF21 signalling to adipose tissues promotes the disposal of excess carbohydrates41,65.”
From Metabolic messengers: FGF21 (2021) · cites this paper as [41]
In the citing paper
“Pharmacological administration of FGF21 decreases plasma glucose and lipid levels, improves insulin and leptin sensitivity, decreases hepatic steatosis, increases energy expenditure [[131], [132], [133], [134], [135], [136]], and decreases sugar and alcohol intake in mice [[137], [138], [139], [140], [141], [142]].”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [132]
In the citing paper
“Pharmacological administration of FGF21 decreases plasma glucose and lipid levels, improves insulin and leptin sensitivity, decreases hepatic steatosis, increases energy expenditure [[131], [132], [133], [134], [135], [136]], and decreases sugar and alcohol intake in mice [[137], [138], [139], [140], [141], [142]].”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [132]
In the citing paper
“Pharmacological administration of FGF21 decreases plasma glucose and lipid levels, improves insulin and leptin sensitivity, decreases hepatic steatosis, increases energy expenditure [[131], [132], [133], [134], [135], [136]], and decreases sugar and alcohol intake in mice [[137], [138], [139], [140], [141], [142]].”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [132]
In the citing paper
“Pharmacological administration of FGF21 decreases plasma glucose and lipid levels, improves insulin and leptin sensitivity, decreases hepatic steatosis, increases energy expenditure [[131], [132], [133], [134], [135], [136]], and decreases sugar and alcohol intake in mice [[137], [138], [139], [140], [141], [142]].”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [132]
In the citing paper
“The acute pharmacological administration of FGF21 increases insulin sensitivity and lowers plasma glucose levels, primarily by stimulating peripheral glucose disposal, while also slightly reducing hepatic glucose production (27, 142).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [142]
In the citing paper
“A single injection of FGF21 to diabetic and obese animal models is sufficient to decrease plasma glucose levels by more than 50% (142).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [142]
In the citing paper
“The half-life of FGF21 is approximately 0.4–2 hours, depending on the species and method of delivery (51, 65, 142).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [142]
Citations
Cites
Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1047 · Cited by 15,297
Method for the Isolation of Intact Islets of Langerhans from the Rat Pancreas
Lacy, P. E., & Kostianovsky, M. (1967) · Diabetes · doi:10.2337/diab.16.1.35 · Cited by 2,741
FGF-21 as a novel metabolic regulator
Kharitonenkov, A., Shiyanova, T. L., Koester, A., Ford, A. M., Micanovic, R., Galbreath, E. J., Sandusky, G. E., Hammond, L. J., Moyers, J. S., Owens, R. A., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23606 · Cited by 2,125
Inagaki, T., Dutchak, P., Zhao, G., Ding, X., Gautron, L., Parameswara, V., Li, Y., Goetz, R., Mohammadi, M., Esser, V., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.003 · Cited by 1,504
Self-citationXu, J., Lloyd, D. J., Hale, C., Stanislaus, S., Chen, M., Sivits, G., Vonderfecht, S., Hecht, R., Li, Y.-S., Lindberg, R. A., et al. (2009) · Diabetes · doi:10.2337/db08-0392 · Cited by 1,151
Self-citationAdvances in Male Contraception
Page, S. T., Amory, J. K., & Bremner, W. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0041 · Cited by 1,138
Evolution of the Fgf and Fgfr gene families.
Itoh, N., & Ornitz, D. (2004) · Trends in Genetics · doi:10.1016/j.tig.2004.08.007 · Cited by 1,123
Identification of a novel FGF, FGF-21, preferentially expressed in the liver
Nishimura, T., Nakatake, Y., Konishi, M., & Itoh, N. (2000) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(00)00067-1 · Cited by 847
The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21
Kharitonenkov, A., Wroblewski, V. J., Koester, A., Chen, Y.-F., Clutinger, C. K., Tigno, X. T., Hansen, B. C., Shanafelt, A. B., & Etgen, G. J. (2007) · Endocrinology · doi:10.1210/en.2006-1168 · Cited by 738
βKlotho is required for metabolic activity of fibroblast growth factor 21
Ogawa, Y., Kurosu, H., Yamamoto, M., Nandi, A., Rosenblatt, K. P., Goetz, R., Eliseenkova, A. V., Mohammadi, M., & Kuro-o, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701600104 · Cited by 617
Research works printed but not linked: 2
- Dostalova I, 2009, Physiol Res/Academia Scientiarum Bohemoslovaca, 58, 1
- Kharitonenkov A, 2009, Curr Opin Investig Drugs, 10, 359
Cited by
Sorted by citations
Items 201–300 of 341
Chen, H., Dardik, B. N., Qiu, L., Ren, X., Caplan, S. L., Burkey, B. F., Boettcher, B. R., & Gromada, J. (2010) · Endocrinology · doi:10.1210/en.2009-1366 · Cited by 22
Biomaterial-Based Therapeutic Strategies for Obesity and Its Comorbidities
Li, J., Duan, H., Liu, Y., Wang, L., & Zhou, X. W. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14071445 · Cited by 23
Nielsen, M. H., Gillum, M. P., Vrang, N., Jelsing, J., Hansen, H. H., Feigh, M., & Oró, D. (2023) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00157.2022 · Cited by 20
Yan, X., Chen, J., Zhang, C., Zeng, J., Zhou, S., Zhang, Z., Lu, X., Chen, J., Feng, W., Li, X., et al. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0241-0 · Cited by 21
Wang, Yu, Zhang, Floyd, Z. E., Lian, Cefalu, & Boudreau (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s30887 · Cited by 21
FGF21 Alleviates Hepatic Endoplasmic Reticulum Stress under Physiological Conditions
Maruyama, R., Shimizu, M., Hashidume, T., Inoue, J., Itoh, N., & Sato, R. (2018) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.64.200 · Cited by 21
Lewis, J. E., Monnier, C., Marshall, H. J., Fowler, M. J., Green, R., Cooper, S., Chiotellis, A., Luckett, J., Perkins, A. C., Coşkun, T., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.10.009 · Cited by 25
Relationship between FGF21 and drug or nondrug therapy of type 2 diabetes mellitus
Guo, C. Y., Zhao, L., Li, Y., Deng, X., & Yuan, G. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29879 · Cited by 21
Self-citationA Novel Approach to Improve the Function of FGF21
Smith, R. W., Duguay, A. N., Weiszmann, J., Stanislaus, S., Belouski, E., Cai, L., Yie, J., Xu, J., Gupte, J., Wu, X., et al. (2013) · BioDrugs · doi:10.1007/s40259-013-0013-x · Cited by 20
Self-citationEmerging roles of fibroblast growth factor 21 in critical disease
Fang, Y., Li, Y., Yang, F., Wu, G., & Jiang, X. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1053997 · Cited by 20
Self-citationCaixeta, L. S., Giesy, S. L., Krumm, C. S., Perfield, J. W., Butterfield, A. M., & Boisclair, Y. R. (2019) · Journal of Dairy Science · doi:10.3168/jds.2019-16696 · Cited by 20
Metabolic Factors Determining the Susceptibility to Weight Gain: Current Evidence
Hollstein, T., & Piaggi, P. (2020) · Current Obesity Reports · doi:10.1007/s13679-020-00371-4 · Cited by 24
Fibroblast Growth Factor 21: A Fascinating Perspective on the Regulation of Muscle Metabolism
Li, S., Chen, J., Wei, P., Zou, T., & You, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316951 · Cited by 19
Insulin sensitizes FGF21 in glucose and lipid metabolisms via activating common AKT pathway
Yu, D., Ye, X., Wu, Q., Li, S., Yang, Y., He, J., Liu, Y., Zhang, X., Yuan, Q., Liu, M., et al. (2015) · Endocrine · doi:10.1007/s12020-015-0801-9 · Cited by 19
The FGFR D3 Domain Determines Receptor Selectivity For Fibroblast Growth Factor 21
Gupte, J., Li, Y., Wu, X., Weiszmann, J., Hecht, R. I., Lemon, B. D., Lindberg, R. A., Wang, Z., & Li, Y. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.03.003 · Cited by 18
Self-citationAndersen, B., Omar, B. A., Rakipovski, G., Raun, K., & Åhrén, B. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.07.003 · Cited by 18
Krumm, C. S., Giesy, S. L., Caixeta, L. S., Perfield, J. W., Sauerwein, H., Moore, B. L., & Boisclair, Y. R. (2019) · Journal of Dairy Science · doi:10.3168/jds.2019-16695 · Cited by 18
Thompson, A. C. S., Bruss, M. D., Nag, N., Kharitonenkov, A., Adams, A. C., & Hellerstein, M. K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111418 · Cited by 17
Fibroblast Growth Factor 21-Null Mice Do Not Exhibit an Impaired Response to Fasting
Antonellis, P. J., Hayes, M. P., & Adams, A. C. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00077 · Cited by 17
Vildagliptin and caloric restriction for cardioprotection in pre-diabetic rats
Tanajak, P., Pintana, H., Siri‐Angkul, N., Khamseekaew, J., Apaijai, N., Chattipakorn, S. C., & Chattipakorn, N. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0406 · Cited by 17
Schlessinger, K., Li, W., Tan, Y., Liu, F., Souza, S. C., Tozzo, E., Liu, K., Thompson, J. R., Wang, L., & Muise, E. S. (2015) · Obesity · doi:10.1002/oby.21153 · Cited by 17
Zhang, M., Liu, Y., Xiong, Z.-Y., Deng, Z., Song, H., & An, Z. (2013) · PubMed · Cited by 17
A Unique FGF23 with the Ability to Activate FGFR Signaling through Both αKlotho and βKlotho
Wu, X., Weiszmann, J., Ge, H., Baribault, H., Stevens, J. L., Hawkins, N., Vonderfecht, S. L., Gardner, J., Gupte, J., Sheng, J., et al. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.02.027 · Cited by 17
Self-citationAlizadeh‐Fanalou, S., Babaei, M., Hosseini, A., Azadi, N. A., Nazarizadeh, A., Shojaii, A., Borji, M., Malekinejad, H., & Bahreini, E. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112331 · Cited by 17
Reduction of Plasma BCAAs following Roux-en-Y Gastric Bypass Surgery Is Primarily Mediated by FGF21
Shah, H., Kramer, A., Mullins, C. A., Mattern, M., Gannaban, R. B., Townsend, R. L., Campagna, S. R., Morrison, C. D., Berthoud, H., & Shin, A. C. (2023) · Nutrients · doi:10.3390/nu15071713 · Cited by 17
Jiang, S., Zhang, R., Li, H., Fang, Q., Jiang, F., Hou, X., Hu, C., & Jia, W. (2014) · Lifestyle Genomics · doi:10.1159/000367943 · Cited by 16
Epperlein, S., Gebhardt, C., Rohde, K., Chakaroun, R., Patt, M., Schamarek, I., Kralisch, S., Heiker, J. T., Scholz, M. R., Stümvoll, M., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9040345 · Cited by 16
Fournier, C., Rizzoli, R., & Ammann, P. (2014) · Endocrinology · doi:10.1210/en.2014-1308 · Cited by 15
Wang, R., Wang, J., Zhang, Z., Ma, B., Sun, S., Gao, L., & Gao, G. (2023) · Molecular Medicine · doi:10.1186/s10020-023-00755-x · Cited by 17
Chen, Q., Cheng, W., Zhang, J., Chi, C., Lin, M., He, C., Liao, Z., & Gong, F. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.09.017 · Cited by 17
Both objective and paradoxical insomnia elicit a stress response involving mitokine production
Martucci, M., Conte, M., Ostan, R., Chiariello, A., Miele, F., Franceschi, C., Salvioli, S., Santoro, A., & Provini, F. (2020) · Aging · doi:10.18632/aging.103274 · Cited by 15
Age-dependent sex difference of non-alcoholic fatty liver disease in TSOD and db/db mice
Dungubat, E., Kusano, H., Mori, I., Tawara, H., Sutoh, M., Ohkura, N., Takanashi, M., Kuroda, M., Harada, N., Udo, E., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0278580 · Cited by 15
Hron, B. M., Ebbeling, C. B., Feldman, H. A., & Ludwig, D. S. (2017) · Nutrition & Metabolism · doi:10.1186/s12986-017-0198-y · Cited by 15
FAP finds FGF21 easy to digest
Gillum, M. P., & Potthoff, M. J. (2016) · Biochemical Journal · doi:10.1042/bcj20160004 · Cited by 14
Pancreatic Tumorigenesis: Oncogenic KRAS and the Vulnerability of the Pancreas to Obesity
Luo, Y., Li, X., Ma, J., Abbruzzese, J. L., & Lu, W. (2021) · Cancers · doi:10.3390/cancers13040778 · Cited by 14
Zhou, Z., Zhang, H., Tao, Y., Zang, J., Zhao, J., Li, H., Wang, Y., Wang, T., Zhao, H., Wang, F., et al. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102877 · Cited by 13
Siemienowicz, K. J., Furmanska, K., Filis, P., Talia, C., Thomas, J. L., Fowler, P., Rae, M. T., & Duncan, W. C. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111196 · Cited by 13
Jiang, Y., Han, J., Li, Y., Wu, Y., Liu, N., Shi, S. X.-Y., Lin, L., Yuan, J., Wang, S., Ning, M., et al. (2021) · Translational Stroke Research · doi:10.1007/s12975-021-00941-1 · Cited by 13
Self-citationBerthou, F., Sobolewski, C., Abegg, D., Fournier, M., Maeder, C., Dolicka, D., de Sousa, M. C., Adibekian, A., & Foti, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073959 · Cited by 14
Therapeutic value of brown adipose tissue
Gunawardana, S. C. (2012) · Adipocyte · doi:10.4161/adip.21042 · Cited by 13
Protein Restriction in Metabolic Health: Lessons from Rodent Models
Na, K., & Park, Y. J. (2024) · Nutrients · doi:10.3390/nu16020229 · Cited by 12
Metabolic signaling functions of the heme oxygenase/CO system in metabolic diseases
Kim, H. J., Joe, Y., Surh, Y., & Chung, H. (2018) · Cellular and Molecular Immunology · doi:10.1038/s41423-018-0045-8 · Cited by 12
Stone, S., Wegner, D., Wambach, J., Cole, F. S., Urano, F., & Ornitz, D. M. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa138 · Cited by 12
Advances in FGFs for diabetes care applications
Liu, Y., Chen, Q., Li, Y., Bi, L., He, Z., Shao, C., Jin, L., Peng, R., & Zhang, X. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121015 · Cited by 12
Self-citationXu, P., Zhang, Y., Song, L., Khoso, M. H., Li, J., Jiang, X., He, J., Li, J., Ma, X., Ren, G., et al. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.09.019 · Cited by 12
KLOTHO, FGF21 AND FGF23: NOVEL PATHWAYS TO MUSCULOSKELETAL HEALTH?
Bartali, B., Semba, R. D., & de Araújo, A. B. (2013) · The Journal of Frailty & Aging · doi:10.14283/jfa.2013.26 · Cited by 12
Tada, A., Misawa, E., Tanaka, M., Saito, M., Nabeshima, K., Yamauchi, K., Abe, F., Goto, T., & Kawada, T. (2020) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.66.176 · Cited by 12
Hofman, M. S., & Hicks, R. J. (2011) · EJNMMI Research · doi:10.1186/2191-219x-1-2 · Cited by 12
The mechanics of anoikis resistance in cancer
Corsini, M., Domenichini, M., Moreschi, E., & Mitola, S. M. F. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189498 · Cited by 11
FGF family in health and disease
Liu, X., Jing, M., Yang, Y., Jin, Q., Feng, B., Zhang, P., Niu, C., Hu, X., & Huang, Z. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00429-0 · Cited by 14
Zhang, X., Zheng, H. X., Ni, Z., Shen, Y., Wang, D., Li, W., Zhao, L., Li, C., & Gao, H. (2024) · Cerebral Cortex · doi:10.1093/cercor/bhad502 · Cited by 11
Zhang, Z., Cui, M., Wang, H., Yuan, W., Liu, Z., Gao, H., Guan, X., Chen, X., Xie, L., He, Y., et al. (2025) · Environmental Pollution · doi:10.1016/j.envpol.2025.125771 · Cited by 11
Reduced adiposity attenuates FGF21 mediated metabolic improvements in the Siberian hamster
Lewis, J. E., Samms, R. J., Cooper, S., Luckett, J., Perkins, A. C., Adams, A. C., Tsintzas, K., & Ebling, F. J. P. (2017) · Scientific Reports · doi:10.1038/s41598-017-03607-x · Cited by 11
Krumm, C. S., Xu, X., Bare, C. J., Holman, C. D., Kersten, S., Dow, L. E., Lee, A.-H., & Cohen, D. E. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100815 · Cited by 11
Myokine Responses to Exercise in a Rat Model of Low/High Adaptive Potential
Farrash, W. F., Phillips, B. E., Britton, S. L., Qi, N., Koch, L. G., Wilkinson, D. J., Smith, K., & Atherton, P. J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.645881 · Cited by 11
FGF21 Analogues and MASLD: A Summary of Preclinical and Clinical Data
Boutari, C., Triantafyllou, A., Papalavrentios, L., Goulis, I., & Sinakos, E. (2025) · Current Pharmaceutical Design · doi:10.2174/0113816128374854250709050425 · Cited by 11
Biology of Stress Responses in Aging
Calubag, M. F., Ademi, I., Yeh, C., Babygirija, R., Bhoopat, A. M., Kasza, I., Sonsalla, M. M., Green, C. L., Pak, H. H., & Lamming, D. W. (2023) · doi:10.59368/agingbio.20230002 · Cited by 10
Research progress on the role of FGF21 in insulin resistance
Zhang, H., Zhu, R., Sun, Q., & Du, L. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1619462 · Cited by 10
Substance Use Affects Type 1 Diabetes Pancreas Pathology: Implications for Future Studies
Bruggeman, B., Campbell‐Thompson, M., Filipp, S. L., Gurka, M. J., Atkinson, M. A., Schatz, D., & Jacobsen, L. M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.778912 · Cited by 9
Solomon, T. P. J., Carter, S., Haus, J. M., Karstoft, K., von Holstein‐Rathlou, S., Nielsen, M. S., & Gillum, M. P. (2022) · PeerJ · doi:10.7717/peerj.12755 · Cited by 10
Kim, D., Lee, J., Bae, I., Kim, M., Huh, Y., Choi, J., Bae, S., Choi, I. Y., Kim, H. H., & Kim, D. K. (2020) · Biologicals · doi:10.1016/j.biologicals.2020.11.005 · Cited by 9
Pancreatic Islet Cell Hormones: Secretion, Function, and Diabetes Therapy
Ma, J., Mao, L., Yang, L., Xie, Q., Fan, R., Lu, X., Huang, X., Tong, N., & Duan, Z. (2025) · MedComm · doi:10.1002/mco2.70359 · Cited by 11
Ho, M., Zhang, C., Moon, I., Biernacka, J. M., Coombes, B. J., Ngo, Q., Skillon, C., Skime, M. K., Oesterle, T., Croarkin, P. E., et al. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101798 · Cited by 8
Adipose Tissue, Hormones, and Treatment of Type 1 Diabetes
Gunawardana, S. C. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0300-9 · Cited by 8
Impact of sex on the adaptation of adult mice to long consumption of sweet-fat diet
Бажан, Н. М., Iakovleva, T., Dubinina, A., & En, M. (2020) · Vavilov Journal of Genetics and Breeding · doi:10.18699/vj20.682 · Cited by 8
Sostre‐Colón, J., Gavin, M. J., Santoleri, D., & Titchenell, P. M. (2022) · Endocrinology · doi:10.1210/endocr/bqac035 · Cited by 7
Бажан, Н. М., Jakovleva, T., Kazantseva, A. Y., Костина, Н. Е., Orlov, P. E., Balybina, N., Baranov, K. O., & En, M. (2023) · Vavilov Journal of Genetics and Breeding · doi:10.18699/vjgb-23-40 · Cited by 9
Low- and high-protein diets do not alter ex vivo insulin action in skeletal muscle
Li, Z., Rasmussen, M. L., Li, J., Henríquez‐Olguín, C., Knudsen, J. R., Søgaard, O. S., Madsen, A. B., & Jensen, T. E. (2018) · Physiological Reports · doi:10.14814/phy2.13798 · Cited by 8
Functions of FGF21 and its role in cardiac hypertrophy
Chen, L., Gao, M., Ong, S., & Gong, G. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.03.007 · Cited by 7
Generation of bispecific antibodies by structure-guided redesign of IgG constant regions
Iwasaki, Y. W., Tharakaraman, K., Subramanian, V., Khongmanee, A., Hatas, A., Fleischer, E., Rurak, T. T., Ngok-ngam, P., Tit-oon, P., Ruchirawat, M., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1063002 · Cited by 7
Fibroblast growth factor-21 improves insulin action in nonlactating ewes
Lamb, C. L., Giesy, S. L., McGuckin, M. M., Perfield, J. W., Butterfield, A. M., Moniruzzaman, M., Haughey, N. J., McFadden, J. W., & Boisclair, Y. R. (2022) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00259.2021 · Cited by 7
Estradiol-dependent and independent effects of FGF21 in obese female mice
Jakovleva, T. V., Kazantseva, A. Y., Dubinina, A. D., Balybina, N. Y., Baranov, K. O., Makarova, E. N., & Бажан, Н. М. (2022) · Vavilov Journal of Genetics and Breeding · doi:10.18699/vjgb-22-20 · Cited by 7
Yu, H., Fan, M., Chen, X., Jiang, X., Loor, J. J., Aboragah, A. A., Zhang, C., Bai, H., Fang, Z., Shen, T., et al. (2022) · Journal of Dairy Science · doi:10.3168/jds.2021-21287 · Cited by 7
Ortiz‐Silva, M., Leonardi, B. F., Castro, É., Peixoto, Á. S., Gilio, G. R., Oliveira, T. E., Tomazelli, C. A., Andrade, M. L., Moreno, M. F., Belchior, T., et al. (2023) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2023.112074 · Cited by 7
Adipose Tissue as an Endocrine Organ
Hui, H., & Feng, T. (2018) · InTech eBooks · doi:10.5772/intechopen.76220 · Cited by 10
Sleeve gastrectomy attenuates high fat diet-induced non-alcoholic fatty liver disease
Pei, E., Liu, Y., Jiang, W., Lin, S., Huang, L., Lin, M., & Cai, L. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0875-5 · Cited by 7
Marshall, J. P. S., Huynh, K., Lancaster, G. I., Ng, J., Collins, J. M., Pernes, G., Liang, A., Featherby, T. J., Mellet, N. A., Drew, B. G., et al. (2024) · iScience · doi:10.1016/j.isci.2024.108800 · Cited by 8
Luo, W., Lin, X., Wang, T., Cai, J., Zeng, X., Zhu, C., Li, R., Wang, H., & Wu, X. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26780 · Cited by 6
Wang, J., Sheu, W. H., Lee, W., Lee, I., Lin, S., Lee, W.-L., Liang, K., & Lin, S. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.07.017 · Cited by 6
Wang, N., Sun, B., Guo, H., Jing, Y., Qi, R., Wang, M., Mi, Y., Chen, H., Song, L., & Cui, W. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.795520 · Cited by 6
Effects of central FGF21 infusion on the glucose homeostasis in rats (brain–pancreas axis)
Tanbek, K., Yılmaz, Ü., Gül, M., Koç, A., & Sandal, S. (2023) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2023.2166964 · Cited by 6
Rama, K., Jahagirdar, V., & Sanyal, A. J. (2026) · Drug Design Development and Therapy · doi:10.2147/dddt.s560034 · Cited by 6
Peng, Z., Gao, L., Zhang, L., Yao, R., Li, X., Deng, L. J., Fan, J., Ying, L., & Wang, Y. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146577 · Cited by 5
Hou, H.-W., Bishop, C. A., Huckauf, J., Broer, I., Klaus, S., Nausch, H., & Buyel, J. F. (2022) · Frontiers in Plant Science · doi:10.3389/fpls.2022.998596 · Cited by 5
Song, L., Ye, H., Lv, Z., Liu, Y., Lu, Z., Chen, J., Pan, H., Cai, L., Chen, Y., Huang, S., et al. (2025) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2025.114650 · Cited by 5
Field-Flow Fractionation for Assessing Biomolecular Interactions in Solution
Chou, R., Pollastrini, J., Dillon, T. M., Bondarenko, P. V., Tam, L. T., Miller, J. M., Moxness, M. S., & Cao, S. (2011) · Springer eBooks · doi:10.1007/978-3-7091-0154-4_8 · Cited by 5
Moreno-Lopez, M., Louvet, I., Delalleau, N., Acosta-Montalvo, A., Thévenet, J., Pasquetti, G., Gmyr, V., Kerr-Conte, J. A., Pattou, F. N., Bonner, C., et al. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16089 · Cited by 4
Huang, Y., Liu, B., Hu, C., & Lu, Y. (2025) · Protein & Cell · doi:10.1093/procel/pwaf027 · Cited by 4
Jackson, T. C., Herrmann, J. R., Fink, E. L., Au, A. K., & Kochanek, P. M. (2023) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000003424 · Cited by 4
Durnwald, C. P., Mele, L., Landon, M. B., Varner, M. W., Casey, B. M., Reddy, U. M., Wapner, R. J., Rouse, D. J., Tita, A., Thorp, J. M., et al. (2020) · American Journal of Perinatology · doi:10.1055/s-0040-1712966 · Cited by 4
Bibliometric analysis of fibroblast growth factor 21 research over the period 2000 to 2021
She, Q.-Y., Li, L., Liu, M.-H., Tan, R.-Y., Zhong, Y.-W., Bao, J., & Xie, J.-D. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1011008 · Cited by 9
O’Neill, L. M., Phang, Y. X., Liu, Z., Lewis, S. A., Aljohani, A., McGahee, A., Wade, G., Kalyesubula, M., Simcox, J., & Ntambi, J. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314671 · Cited by 4
Therapeutic potential of FGF21 in diabetes
Davis, D., Garg, C., & Lahiri, S. (2017) · Journal of Medicinal Plants Studies · Cited by 4
Lu, S., Liu, G., Chen, T., Wang, W., Hu, J., Tang, D., & Peng, X. (2020) · Human Gene Therapy · doi:10.1089/hum.2019.322 · Cited by 3
Self-citationAntwi, S., Oduro‐Mensah, D., Asiedu-Larbi, J., Oduro‐Mensah, E., Quasie, O., Lewis, C., Darko, D. O., Ocloo, A., & Okine, L. K. (2022) · Journal of Inflammation · doi:10.1186/s12950-022-00301-2 · Cited by 4
Qi, J., Guo, Z., Zhu, S., Jiang, X. J., Wu, Y., Chen, Y., Hu, F., Xiong, J., Wu, Y., Ye, X., et al. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.129797 · Cited by 3
Maffeis, C., Morandi, A., Zusi, C., Olivieri, F., Fornari, E., Cavarzere, P., Piona, C. A., Corradi, M., Emiliani, F., Ros, A. D., et al. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16081 · Cited by 3
Guerrero, J. G., Ishida, E., Shibusawa, N., Lei, X., Yamada, S., Horiguchi, K., & Yamada, M. (2022) · Thyroid · doi:10.1089/thy.2022.0144 · Cited by 3
Zhang, X., Li, Z., Wang, S., & Chen, Y. (2025) · Nutrients · doi:10.3390/nu17071179 · Cited by 2
Turner, M. B., Pangilinan, H., Park, S., Angoma, B., Helsley, R. N., & Loria, A. S. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70230 · Cited by 2
Metadata
- Authors
- Xu, J., Stanislaus, S., Chinookoswong, N., Lau, Y. Y., Hager, T., Patel, J., Ge, H., Weiszmann, J., Lu, S.-C., Graham, M., Busby, J., Hecht, R., Li, Y.-S., Li, Y., Lindberg, R., & Véniant, M. M.
- Affiliations
- Departments of1 Metabolic Disorders,
- Pharmacokinetics and Drug Metabolism, and
- Amgen (United States) (US)
- Protein Sciences, Amgen Inc., Thousand Oaks; and
- Corresponding author
- Xu, Jing
- Venue
- American Journal of Physiology-Endocrinology and Metabolism
- Publisher
- American Physiological Society
- Published
- 2009-11
- Volume
- 297
- Issue
- 5
- Pages
- E1105-E1114
- ISSN
- 0193-1849 (ISSN-L)
- 1522-1555
- OpenAlex
- W2061333499
- Cited by
- 340
- References
- 28
- Citations by year
- 2026: 14 · 2025: 17 · 2024: 17 · 2023: 21 · 2022: 30 · 2021: 22 · 2020: 22 · 2019: 28 · 2018: 22 · 2017: 29 · 2016: 23 · 2015: 14 · 2014: 23 · 2013: 16 · 2012: 19
- FWCI
- 5.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Physiology-Endocrinology and Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Amgen
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- FGF21, insulin resistance, glucose tolerance, insulin sensitivity, hepatic glucose production, adipose tissue, FGF signaling, ob/ob mice, diet-induced obesity, amylin, glucagon, hepatoma cells, adipocytes, glucose uptake
- MeSH terms
- Adipose Tissue, Animals, Cell Differentiation, Diet, Dose-Response Relationship, Drug, Enzyme-Linked Immunosorbent Assay, Fibroblast Growth Factors, Humans, Hypoglycemic Agents, Insulin Resistance, Islets of Langerhans, Liver, Liver Neoplasms, Experimental, Male, Mice, Inbred C57BL, Mice, Obese, Obesity, Recombinant Proteins, Blotting, Western, Glucose Clamp Technique, Adipocytes, Area Under Curve, 3T3-L1 Cells, Cell Line, Tumor, Mice, Islet Amyloid Polypeptide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
